FAQ

1. What does Intrexon do?

Intrexon Corporation, founded in 1998, is a biotechnology company focused on collaborating with companies in Health, Food, Energy, and Environment to create biologically based products that improve quality of life and the health of the planet. At present rates of global industrialization and population growth, food and energy supplies and environmental and healthcare resources are becoming scarcer. We believe Intrexon’s leading Better DNA™ approach to synthetic biology has the potential to provide new, more effective and sustainable solutions to address these challenges. 

With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Working with key collaborators, Intrexon seeks to develop high value applications that can bring better medicines to more people, alleviate shortages of essential nutrients, develop renewable fuels and other resources, and protect the environment.

2. Where is Intrexon’s principal corporate office?

Intrexon’s principal corporate office is located at: 
20374 Seneca Meadows Parkway 
Germantown, Maryland 20876 
Telephone: (301) 556-9900

3. When was Intrexon founded and where was it incorporated?

The Company was founded by Thomas D. Reed, Ph.D., in 1998, as an Ohio limited liability company under the name Genomatix LTD. The Company was reincorporated as a Virginia corporation in 2004 and changed its name to Intrexon Corporation in 2005.

4. On what exchange does Intrexon trade and what is its stock symbol?

Shares of Intrexon trade on the New York Stock Exchange under the symbol XON.

5. Can shares of Intrexon be purchased directly through the Company?

No, Intrexon does not offer a direct investment program. Interested investors may purchase shares through any registered broker.

6. Who underwrote the IPO?

J.P. Morgan Securities LLC and Barclays Capital Inc. served as joint book-running managers for the offering.

7. When was Intrexon’s initial public offering? How many shares were offered and at what price?

The Company closed its initial public offering of on August 13, 2013. The Company announced the total number of shares sold was 11,499,998, composed of 9,999,999 shares initially offered and an additional 1,499,999 shares sold pursuant to the full exercise of the underwriters’ over-allotment option, in each case at an initial public offering price of $16.00 per share. All of the common stock was sold by Intrexon.

8. When is Intrexon’s fiscal year end?

Intrexon’s fiscal year end is December 31.

9. When is Intrexon’s next earnings release?

Intrexon reports earnings results on a quarterly basis. For our upcoming earnings announcements and other investor events, please see our Calendar of Events.

10. Who are Intrexon’s officers and directors?

The names of the Company’s officers and directors, as well as their biographies, can be found in the Management Team and Board of Directors sections of the website.

11. Who is Intrexon’s independent auditor?

The Company’s independent auditor is PricewaterhouseCoopers LLC.

12. Who is Intrexon’s transfer agent?

The Company’s transfer agent is: 
American Stock Transfer & Trust Company, LLC., 
6201 15th Avenue, Brooklyn, NY 11219
(800) 937-5449

13. Who do I contact to request information on my account or change my account information?

For questions concerning stock holdings, certificate replacement/transfer, and address changes, please contact our transfer agent: 
American Stock Transfer & Trust Company, LLC 
Shareholder Relations Services Department 
6201 15th Avenue, Brooklyn, NY 11219 
(800) 937-5449

14. How do I access information on Intrexon’s SEC filings? How can I obtain a copy of the annual report?

Annual 10-K reports, quarterly 10-Q reports, proxy statements and other filings with the SEC can be accessed directly through the SEC Filings section of Intrexon’s website or through the Securities and Exchange Commission at www.sec.gov. If you would like a hard copy of the annual report, please submit your request through our Information Request form.

15. Where can I find more information regarding my shareholder rights and the proxy voting process?

Shareholders can access general educational information on shareholder rights and the proxy voting process on third party sites. Below are several links that may be helpful to shareholders: 
 

16. How may an interested party communicate with the lead independent director or with the independent directors?

Interested parties may contact these persons as directed in Appendix B to our Corporate Governance Guidelines.

17. How can I find information on career opportunities with Intrexon?

For information on career opportunities at Intrexon, please visit the Careers section of the Company’s website.

18. Do you have further questions concerning Intrexon that have not been answered?

Go to the Information Request page.


print email